They isolated TIL and peripheral blood lymphocytes (PBL) from 21 GBM patients and assessed for the presence of multiple immune checkpoint markers including PD-1, CTLA-4, TIM-3, LAG-3, CD160, 2B4, TIGIT, CD39, and BTLA [96]. The gene discussed is HAVCR2; the disease is glioblastoma.